Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BOTOX Treatment in Adult Patients with Upper Limb Spasticity

Next Previous
Trial Profile

BOTOX Treatment in Adult Patients with Upper Limb Spasticity

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 14 Jan 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Muscle spasticity
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergan

Most Recent Events

  • 28 Apr 2017 Preliminary results of this trial assessing safety and efficacy presented at the 69th Annual Meeting of the American Academy of Neurology.
  • 20 Apr 2017 According to an Allergan media release, data from this study will be presented at the upcoming 69th American Academy of Neurology (AAN) annual meeting.
  • 02 Oct 2015 Planned end date changed from 1 Mar 2016 to 1 Dec 2015, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top